Searched for
OSTEOARTHRITIS PAIN
Doctors find new non-surgical treatment for osteoarthritis patients that may relieve knee pain in weeksA groundbreaking minimally invasive procedure, knee embolization, is offering new hope for knee osteoarthritis sufferers. Developed by Colu...- Eli Lilly says next-gen obesity drug curbs sleep apnea, among other benefitsEli Lilly presented trial results for its new obesity drug retatrutide. The drug significantly reduced sleep apnea severity and knee osteoa...
- Social media is abuzz with weight-loss drug retatrutide and longevity goals. What is the drug all about?A new weight-loss drug, retatrutide, is generating excitement. This investigational medicine targets three hormone receptors, offering a po...
- Struggling with knee pain? New study says the cure starts with movement, not rest: Try these exercises to ease pain within weeksNew research published in The BMJ and reported by Women’s Health reveals that movement, not rest, is the key to easing knee pain caused by ...
- Study reveals a simple technique to ease knee arthritis pain, and it can be as effective as medication: What is gait retraining?A new study in The Lancet Rheumatology suggests gait retraining — making subtle changes to walking patterns — can ease knee osteoarthritis ...
- Arthritis pain relief without drugs or surgery, study suggestsArthritis, a disorder affecting nearly one in four adults over 40, remains a resulting source of constant pain and disability. Osteoarthrit...
- Yoga vs Strengthening exercises: Which is better for knee osteoarthritis? Study reveals surprising resultsA recent study indicates yoga is as effective as strengthening exercises for managing knee osteoarthritis, offering improvements in pain, q...
- Sun Pharma-Moebius Medical anti-osteoarthritis pain drug gets USFDA fast track statusSun Pharma and Moebius Medical have received fast track designation from the USFDA for their non-opioid therapy MM-II, aimed at treating os...
- Sun Pharma-Moebius Medical anti-osteoarthritis injection shows sustained pain relief in clinical trialsSun Pharma and Moebius Medical announced that their intra-articular injection MM-II showed greater pain relief than placebo for up to 26 we...
- One billion people globally to have osteoarthritis by 2050: Lancet StudyBy 2050, nearly one billion people globally are projected to be living with osteoarthritis, according to a study published in The Lancet Rh...
- Pain relievers may worsen arthritis inflammation, study finds"To date, no curative therapy has been approved to cure or reduce the progression of knee osteoarthritis," said the study's lead author, Jo...
- Great news for osteoarthritis patients! New study says walking can ward off knee painPeople who walked for just 10 mins had less structural damage to their knees.
- Unichem Labs gets American drug regulator's nod to market generic Celecoxib capsulesThe company has received abbreviated new drug application (ANDA) approval for its Celecoxib capsules in the strengths of 50 mg, 100 mg, 200...
- Lupin launches generic drug in the US marketThe Mumbai-based drug firm's product is the generic equivalent of Zyla Life Sciences' Vivlodex Capsules (5 mg and 10 mg). The capsules are ...
- Sun Pharma, Moebius Medical to develop osteoarthritis pain productMM-II is an intra-articular bio lubricant injection which is being developed to provide symptomatic relief of mild-to-moderate osteoarthrit...
- Lupin gets USFDA nod for Diclofenac capsules' generic versionLupin has 139 product filings pending approval with the USFDA. Cumulative filings with the USFDA now stand at 341 with the company having r...
- Paracetamol useless in relieving low back painThe study on paracetamol found that there was never a systematic review of the evidence for the drug's usage to treat low back pain.
- Glenmark's neuropathic drug candidate ready for trialsDrug maker Glenmark Pharmaceuticals said its candidate for neuropathic, osteoarthritis and other inflammatory pain GRC 10693, is entering p...
- Wockhardt to market arthritis drug with Italian companyPharmaceutical company Wockhardt on Wednesday said it has entered into an agreement with Italy-based Gnosis SpA to market a process-patente...
- Glenmark eyes pain management marketGlenmark Pharmaceuticals on Monday said its Swiss subsidiary has completed phase I clinical trials for GRC 6211, a pain reliever, and plans...
Load More
